Full Text View
Tabular View
Study Results
Related Studies
Apremilast in the Treatment of Moderate to Severe Acne
This study has been terminated.
( lack of funding due to Celgene administrative decision )
Study NCT01074502   Information provided by University of North Carolina, Chapel Hill

First Received on February 22, 2010.   Last Updated on March 8, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acne
Additional conditions recognized in this trial
Acne Vulgaris
More general conditions related to this trial
Acneiform Eruptions
Facial Dermatoses
Sebaceous Gland Diseases
Skin Diseases
Interventions listed in this trial
apremilast
Sponsors listed in this trial
University of North Carolina, Chapel Hill
Celgene Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services